Ask Our Experts September 19, 2023 New Study: 10,000 steps is not the magical number 10,000 steps. The gold standard. The magical number we aim to reach daily and perhaps beat ourselves up over when we don’t. It turns out, this number is not based on scientific … Read More
Ask Our Experts September 19, 2023 New treatment for postpartum depression Postpartum depression can occur during the late stages of pregnancy or within 4 weeks after giving birth. Approximately 15% of new mothers develop postpartum depression, which is more severe than the common … Read More
Ask Our Experts September 19, 2023 Air quality and your health This summer, more than 120 million Americans were under air quality alerts as smoke from Canadian wildfires drifted into the United States.1 During this time, the CDC reported a 17% increase in … Read More
Ask Our Experts September 19, 2023 Fall Vaccine Checklist Last winter COVID-19, the flu, and RSV (respiratory syncytial virus) hit the population hard. Typical seasonal viral patterns were altered by the pandemic, and viral activity has been unpredictable. With COVID-19 cases … Read More
News August 16, 2023 PHM Launches ClearCancerIQ™, a Proprietary Predictive Tool for Employers Seeking to Improve CancerCare and Reduce Spend PHM introduces ClearCancerIQ (CCIQ), the first-of-its-kind predictive analytics tool designed to help employers size their company’s cancer risk through quantitative analysis of their health plan population. An innovation in PHM’s ClearCancer™ suite of solutions, CCIQ enables companies to develop high impact strategies to manage cancer at both the employee and workforce level. Read More
News July 11, 2023 Innovative treatment for prostate cancer shows long term success PHM believes in the importance of having access to cutting-edge cancer diagnostics and therapeutics, and we are excited to announce our peer-reviewed case report in Frontiers in Oncology demonstrating why. This report summarizes the case of a 73 year-old male who went from stage 4B prostate cancer to disease free. Our client first came to PHM after a year of his diagnosis and there were early signs that standard treatments were not going to adequately control his disease. We connected him to a clinic in Germany using theranostics, a treatment for prostate cancer that was not yet approved in the U.S. He remains disease free five years later. Read More
